Evaluation of Five Survival Scores in a Cohort of Elderly Patients With Cerebral Metastasis from Non-small Cell Lung Cancer

Anticancer Res. 2020 May;40(5):2847-2851. doi: 10.21873/anticanres.14259.

Abstract

Background/aim: Survival scores are important for treatment personalisation. A score for older patients with cerebral metastasis from non-small cell lung cancer (NSCLC) was generated.

Patients and methods: Dose-fractionation of whole-brain irradiation, age, gender, general condition, histology, count of cerebral lesions, extra-cerebral metastatic spread and time between NSCLC-diagnosis and whole-brain irradiation were analysed for survival in 285 patients. Independent prognostic characteristics were utilised for the score, which was compared against five others.

Results: Based on general condition (p<0.001) and extra-cerebral spread (p=0.003), three groups were generated according to the score, 2 (n=49), 4-6 (n=206) and 7 (n=30) points. Positive predictive values (PPVs) to predict death ≤6 months and survival for ≥6 months were 100% and 52%, respectively. PPVs of other scores were 88-98% and 60-63%.

Conclusion: The accuracy of the new score to predict death within ≤6 months was optimal, whereas its accuracy to predict survival for ≥6 months was lower when compared to the other low PPVs of existing scores.

Keywords: Non-small cell lung cancer; cerebral metastasis; elderly; radiation therapy; survival scores.

MeSH terms

  • Aged
  • Brain Neoplasms / mortality*
  • Brain Neoplasms / secondary
  • Carcinoma, Non-Small-Cell Lung / complications*
  • Carcinoma, Non-Small-Cell Lung / mortality
  • Cohort Studies
  • Female
  • Humans
  • Lung Neoplasms / complications*
  • Lung Neoplasms / mortality
  • Male
  • Neoplasm Metastasis
  • Prognosis
  • Survival Rate